SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001447028-22-000037
Filing Date
2022-05-26
Accepted
2022-05-26 16:17:55
Documents
2
Period of Report
2022-05-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165359625754672.html 4  
1 FORM 4 wf-form4_165359625754672.xml 4 4089
2 POA - BURGESS poa-burgess.htm EX-24 3327
  Complete submission text file 0001447028-22-000037.txt   8992
Mailing Address C/O HOLLIS-EDEN PHARMACEUTICALS 4435 EASTGATE MALL STE.400 SAN DIEGO CA 92121
Business Address
BURGESS DANIEL D (Reporting) CIK: 0001239650 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34949 | Film No.: 22970298

Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations